Microbial nitroreductase enzyme (Nitroreductase (NTR))

Microbial nitroreductase enzymes are FMN-dependent oxidoreductases widely found in bacteria, with some homologs in archaea and eukaryotes[2][4]. They catalyze the reduction of nitro groups on aromatic or heterocyclic compounds to amino or hydroxylamino groups, using NAD(P)H as electron donor via a ping-pong bi-bi reaction mechanism[2][5][6]. Nitroreductases are primarily classified into Type I (oxygen-insensitive, two-electron transfer) and Type II (oxygen-sensitive, one-electron transfer) enzymes[2]. In biotechnology and medicine, microbial nitroreductases are exploited for gene-directed enzyme-prodrug therapy, where they activate prodrugs like metronidazole and CB1954 into cytotoxic forms, enabling targeted ablation of cells expressing NTR (e.g., in cancer or transgenic disease models)[1][5][7]. They also play roles in antibiotic resistance (by reduction of nitroaromatic antibiotics) and environmental detoxification, such as the bioremediation of explosives like TNT[4][8]. Their substrate specificity, structure, and catalytic mechanisms have been extensively studied and engineered to optimize therapeutic and environmental applications[1][2][3][5].

Other names

nitroreductasebacterial nitroreductaseNTRFMN-dependent nitroreductaseNAD(P)H nitroreductase

Catalyzes the two-electron (mainly Type I) or one-electron (Type II) reduction of nitro groups on aromatic/heterocyclic rings to form reactive amino/hydroxylamino intermediates - Drug/prodrug activation: converts non-toxic prodrugs into cytotoxic agents via nitro group reduction - Antibiotic activity modulation: reduces nitroaromatic antibiotics